USA: US drug giant to spin-off Monsanto agriculture business, cites falling sales
US drugs giant Pharmacia Corp. has revealed its intention to sell its remaining 85% stake in agricultural giant Monsanto during the second half of 2002, to allow it to focus on its core pharmaceuticals business. CEO Fred Hassan announced the planned spin-off during a meeting with analysts and investors in New York yesterday. The deal will involve a tax-free dividend for the shareholders that control the remaining 15% of the business since its was floated in an IPO (initial public offering) during the fourth quarter of 2000.
Get full access to all content, just $1 for 30 days
A Message From The Editor
just-food gives you the widest food market coverage.
Paid just-food members have unlimited access to all our exclusive content - including 17 years of archives.
I am so confident you will love complete access to our content that today I can offer you 30 days access for $1.
It’s our best ever membership offer – just for you.
Dean Best, editor of just-food
- General Mills sales woes continue - analysis
- Why personalisation will take-off in US food
- US food next wave on display at Winter Fancy Food
- Comment: Meal kits in US - don't believe the hype
- Analysis: Chocolate sector's deforestation pledge
- Kraft Heinz cuts jobs in US, Canada
- Mondelez set for union crosshairs next week
- Mondelez plays down impact of union action
- Recipe-kit firm HelloFresh launches into UK retail
- Germany's Haribo plans first US candy plant